ArticlePreventive medicine reports2025
Association of accelerated biological aging with kidney stone: Insights from the U.S. National health and nutrition examination survey.
Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Biological age is a more accurate measure of aging than chronological age. This study examines the association between biological age and the prevalence of kidney stones. Methods: Data were sourced from the U.S. National Health and Nutrition Examination Survey 2007-2018 cycles. Biological age was assessed using the Klemera-Doubal Method (KDM-Age) and Phenotypic Age (Pheno-Age). Residuals from the regression of biological age measures on chronological age were computed to determine KDM-Age and Pheno-Age acceleration. Weighted chi-square tests, linear trend analyses, and multivariable logistic regression models were used. Results: A total of 17,905 people were included. The weighted prevalence of kidney stones significantly rose with increasing quartiles of chronological age, KDM-Age, and Pheno-Age in the overall population, and across sex and age subgroups. Significant increasing trends in prevalence were observed across Pheno-Age acceleration quartiles for sex and age subgroups, especially in males and younger individuals (< 65 years) (P for linear trend <0.001). No significant trends were observed for KDM-Age acceleration quartiles in any subgroup. Higher Pheno-Age acceleration was significantly associated with an elevated risk of kidney stones (OR = 1.32, 95 % CI: 1.12-1.55), with notably stronger associations observed in males and younger individuals. Conclusions: Elevated Pheno-Age levels are associated with an increased prevalence of kidney stones, particularly among males and younger individuals. These findings underscore the potential utility of Pheno-Age in identifying individuals at high risk for kidney stones and facilitating early intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.